Contraindications to Allopurinol
The primary absolute contraindication to allopurinol is a history of severe hypersensitivity reactions to the drug, including allopurinol hypersensitivity syndrome (AHS), Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), or DRESS syndrome 1, 2. Additionally, allopurinol is contraindicated in patients who test positive for the HLA-B*58:01 genetic variant 3, 4.
Absolute Contraindications
Prior Severe Hypersensitivity Reactions
Never rechallenge patients who have experienced severe cutaneous adverse reactions (SCARs), including:
- Allopurinol hypersensitivity syndrome (AHS) - characterized by erythematous desquamating rash, fever, hepatitis, eosinophilia, and worsening renal function with 25% mortality 3, 5
- Stevens-Johnson syndrome/Toxic epidermal necrolysis 6
- DRESS syndrome (Drug Reaction with Eosinophilia and Systemic Symptoms) 2, 7
Allopurinol desensitization should only be attempted in patients with mild hypersensitivity reactions (minor rash), and is absolutely contraindicated in those with severe reactions or AHS 1
HLA-B*58:01 Positive Genotype
- The 2015 CPIC guidelines state that allopurinol is contraindicated in persons of any ethnicity with a positive genetic test for HLA-B*58:01 3
- This variant increases the odds of hypersensitivity by 80-580 fold 3
- Preemptive genetic testing is recommended for:
Asymptomatic Hyperuricemia
- According to FDA labeling and multiple guidelines, allopurinol is NOT indicated for asymptomatic hyperuricemia 2, 8, 9
- The 2020 ACR guidelines conditionally recommend against initiating ULT in patients with asymptomatic hyperuricemia (SU >6.8 mg/dL with no prior gout flares or tophi) 8
- This is not innocuous therapy - the potential for severe adverse reactions outweighs uncertain benefits 2, 9
Relative Contraindications and High-Risk Situations
Concurrent Medications
- Avoid co-administration with purine antimetabolites (azathioprine, 6-mercaptopurine) - allopurinol inhibits their metabolism, leading to severe toxicity 10
- This makes allopurinol relatively contraindicated in organ transplant recipients on azathioprine 10
- Ampicillin/amoxicillin increases risk of rash when given with allopurinol 2, 11
Renal Impairment
While not an absolute contraindication, severe renal impairment requires extreme caution:
- Standard doses (200-400 mg/day) in patients with renal insufficiency are associated with most cases of life-threatening AHS 5
- Oxipurinol (active metabolite) accumulates when creatinine clearance is reduced 5, 12
- Must dose-adjust according to creatinine clearance - start at 50-100 mg/day and titrate slowly 13, 14
- Thiazide diuretics combined with renal impairment further increase hypersensitivity risk 11
Critical Clinical Pitfalls
Most dangerous scenario: Prescribing standard allopurinol doses (300 mg/day) to patients with renal insufficiency - this accounts for the majority of severe AHS cases 5. The combination of renal impairment, thiazide diuretics, and standard dosing creates particularly high risk 11.
Timing matters: Most hypersensitivity reactions occur within 8-9 weeks of starting allopurinol 15. Patient education at initiation about immediately stopping the drug if rash, fever, or systemic symptoms develop is essential 15.
Cross-reactivity: Up to 40% of patients show cross-reactivity between allopurinol and oxipurinol; febuxostat (non-purine xanthine oxidase inhibitor) may have less cross-reactivity but this hasn't been directly studied 1.
Alternative Therapies When Allopurinol is Contraindicated
When allopurinol cannot be used 13, 1:
- Febuxostat - alternative xanthine oxidase inhibitor (but may have similar risks in severe prior reactions)
- Uricosuric agents (probenecid, benzbromarone) - if normal renal function and no urolithiasis
- Pegloticase - for severe refractory tophaceous gout when all other options have failed 13